The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Synaptogenix, Inc., an emerging biopharmaceutical company developing therapeutics for neurodegenerative disorders, applauds the reported move by the U...
read more
KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene ...
read more
Wacker Biotech US, a subsidiary of WACKER, specializing in the fermentative production of plasmid DNA (pDNA), is expanding its mRNA and protein ...
read more
MannKind Corporation announced that the FDA granted Fast Track designation of Clofazimine Inhalation Suspension (MNKD-101) for the treatment of ...
read more
Kindeva Drug Delivery announced its investment in a second manufacturing line for the production of pressurized metered-dose inhaler (pMDI) products ...
read more
Ipsen announced the appointment of Keira Driansky as EVP, President of North America, effective May 13, 2024. She will serve on the Executive ...
read more
Astellas Pharma Inc. and Poseida Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos") and ...
read more
Editas Medicine, Inc. announced a two-year extension to the collaboration with Bristol Myers Squibb under which the parties may research, develop, and...
read more
Increasing incidence of cancer followed by awareness for early diagnosis, growing investments in research and development of cancer biomarkers, ...
read more
The advancement path of the global pharmaceutical glass packaging market will be carved promisingly at a CAGR of 9.5%, enabling the market growth ...
read more
Phosphorex, an Ampersand Capital Partners company and drug delivery-focused contract development and manufacturing organization ("CDMO"), announced ...
read more
Harmony Biosciences (Nasdaq: HRMY), today announced the acquisition of Epygenix Therapeutics, Inc., accelerating its growth strategy by adding a rare ...
read more
TriLink BioTechnologies has signed a non-exclusive License and Supply Agreement with Lonza. This agreement with Lonza strengthens TriLink’s objective ...
read more
The FDA announced it will host a listening session in June as part of its broader work to optimize the use of, and processes for, advisory committees....
read more
Pfizer Inc. and Genmab A/S announced that the FDA approved the supplemental Biologics License Application (sBLA) granting full approval for TIVDAK® (...
read more